Published by Josh White on 20th February 2025
(Sharecast News) - Shares in Indivior were sliding on Thursday, even after it reported a better-than-expected end to a difficult year, with a 9% increase in full-year 2024 net revenue to $1.19bn amid continued growth in its opioid use disorder treatment Sublocade.
URL: http://www.digitallook.com/dl/news/story/34893359/...